Loading…
STAAR, a phase I/II study of isaralgagene civaparvovec (ST-920) gene therapy in adults with Fabry disease: Dose escalation phase results
Saved in:
Published in: | Molecular genetics and metabolism 2023-02, Vol.138 (2), p.107152, Article 107152 |
---|---|
Main Authors: | , , , , , , , , , , , , , , , , , |
Format: | Article |
Language: | English |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | |
---|---|
ISSN: | 1096-7192 1096-7206 |
DOI: | 10.1016/j.ymgme.2022.107152 |